CrownBio Launches New Humanized Target Model for Immunotherapy – GlobeNewswire (press release)
GlobeNewswire (press release) |
CrownBio Launches New Humanized Target Model for Immunotherapy
GlobeNewswire (press release) SAN DIEGO, April 26, 2018 (GLOBE NEWSWIRE) — Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:6554) and a global drug discovery and development services company providing translational platforms to advance oncology … |
